P. BARDIN (Paris, France), J. Koranteng (London, United Kingdom)
Transcriptome analysis indicates more AT2-to-AT1 transition in COPD
Z. Cheng (Groningen, Netherlands), S. Bartel (Groningen, Netherlands), J. Nijnatten (Groningen, Netherlands), R. Bults (Groningen, Netherlands), C. Brandsma (Groningen, Netherlands), W. Timens (Groningen, Netherlands), A. Faiz (Sydney, Australia), R. Gosens (Groningen, Netherlands), M. Berge (Groningen, Netherlands), M. Hylkema (Groningen, Netherlands)
|   |
Aging and senescence in alveolar epithelial type II cells affect progenitor cell function and aggravate acute lung injury
C. Brandenberger (Hannover, Germany), M. Hirsch (Hannover, Germany), C. Hildebrand (Hannover, Germany), C. Mühlfeld (Hannover, Germany), D. Wedekind (Hannover, Germany)
| |
Activation of the PPARg pathway to restore mesenchymal stem cell niche properties and induce alveolar regeneration in elastase induced emphysema
G. Justeau (Créteil, France), M. Toigo (Créteil, France), L. Crepin (Créteil, France), J. Boczkowski (Créteil, France), B. Ribeiro (Créteil, France), L. Boyer (Créteil, France)
| |
Oxidative stress is a key driving mechanism in the pathogenesis of inflammatory lung diseases
p. he (Sydney, Australia), M. Papanicolaou (Sydney, Australia), S. Rutting (Sydney, Australia), D. Reddy (Sydney, Australia), A. Ammit (Sydney, Australia), D. Xenaki (Sydney, Australia), D. Van Reyk (Sydney, Australia), B. Oliver (Sydney, Australia), K. Reddy (Glebe, Australia)
| |
Hydrogen sulfide attenuates cigarette smoke-induced oxidative stress and inflammation in human primary bronchial epithelial cells and experimental COPD
V. Kumar (Newcastle, Australia), J. Horvat (Newcastle, Australia), P. Wark (Newcastle, Australia), M. Whiteman (Exeter, United Kingdom), P. Hansbro (Sydney, Australia)
| |
Effect of cigarette smoke exposure on airway epithelial barrier function in never-smokers and ex-smokers with and without COPD
K. Nwozor (Vancouver, Canada), Q. Chen (Groningen, Netherlands), Y. Yang (Vancouver, Canada), X. Zheng (Groningen, Netherlands), T. Kole (Groningen, Netherlands), D. Slebos (Groningen, Netherlands), K. Klooster (Groningen, Netherlands), M. Van Den Berge (Groningen, Netherlands), T. Hackett (Vancouver, Canada), C. Brandsma (Groningen, Netherlands), I. Heijink (Groningen, Netherlands)
| |
Electronic cigarette liquids impair protein synthesis and alter proteomic profiles in V79 cells
M. Ljujic (Belgrade, Republic of Serbia), S. Trifunovic (Split, Croatia), K. Smiljanic (Belgrade, Republic of Serbia), F. Solari (Dortmund, Germany), A. Sickmann (Dortmund, Germany), A. Divac Rankov (Belgrade, Republic of Serbia)
| |
Translational chronic drug-induced ILD mouse model, characterized by low-grade inflammation, fibrosis and dilated large airways
I. Mahmutovic Persson (Lund, Sweden), J. Liu (Lund, Sweden), R. In 'T Zandt (Lund, Sweden), N. Fransén Petterson (Lund, Sweden), A. Örbom (Lund, Sweden), H. Falk-Håkansson (Lund, Sweden), C. Carvalho (Lund, Sweden), K. Von Wachenfeldt (Lund, Sweden), L. Olsson (Malmö, Sweden)
| |
Exposure to nicotine containing e-cigarette vapor leads to endothelial barrier dysfunction and increased susceptibility to LPS in-vitro
B. Seeliger (Hannover, Germany), T. Pape (Hannover, Germany), P. Horn (Birmingham, United Kingdom), K. Stahl (Hannover, Germany), J. Schmidt (Hannover, Germany), T. Welte (Hannover, Germany), A. Prasse (Hannover, Germany), N. Sommer (Giessen, Germany), S. David (Zurich, Switzerland)
| |
A lung and kidney specific fragment of type IV collagen is associated with increased mortality in idiopathic pulmonary fibrosis
A. Hummersgaard Hansen (Herlev, Denmark), T. Prior (Aarhus, Denmark), D. Leeming (Herlev, Denmark), M. Karsdal (Herlev, Denmark), J. Sand (Herlev, Denmark), E. Bendstrup (Aarhus, Denmark)
| |
Disruption of prostaglandin F2a receptor signaling attenuates fibrotic remodeling in a preclinical murine model of idiopathic pulmonary fibrosis
M. Beers (Philadelphia, United States), S. Tang (Philadelphia, United States), L. Rodriguez (Philadelphia, United States), Y. Tomer (Philadelphia, United States), A. Murthy (Philadelphia, United States), T. Cai (South San Francisco, United States), C. Connelly (South San Francisco, United States), A. Gillich (South San Francisco, United States), Y. Wong (South San Francisco, United States), G. Fitzgerald (Philadelphia, United States)
| |
WNK1 signaling after loss of CFTR function in pneumonia-induced lung barrier failure
L. Kneller (Berlin, Germany), L. Erfinanda (Berlin, Germany), W. Kuebler (Berlin, Germany), M. Witzenrath (Berlin, Germany), B. Gutbier (Berlin, Germany)
| |
Air pollution induced emphysema in ageing rats via Hippo signaling pathway
V. Laiman (Taipei, Taiwan), H. Chuang (Taipei, Taiwan)
| |
Interleukin-1 alpha counteracts transforming growth factor-ß2 signaling in lung extracellular matrix remodeling.
K. Usman (Vancouver, Canada), M. Fouadi (Vancouver, Canada), E. Osei (Vancouver, Canada), T. Hackett (Vancouver, Canada)
| |
Greenspace and children’s lung function in China
T. Ye (Melbourne, Australia), Y. Guo (Melbourne, Australia), M. Abramson (Melbourne, Australia), T. Li (Beijing, China), S. Li (Melbourne, Australia)
| |
Late Breaking Abstract - Exposure to particulate matter alters neutrophil lysosomal function and activation status
E. Watts (Edinburgh, United Kingdom), R. Huff (Vancouver, Canada), C. Rider (Vancouver, Canada), M. Whyte (Edinburgh, United Kingdom), S. Walmsley (Edinburgh, United Kingdom), C. Carlsten (Vancouver, Canada)
| |
Late Breaking Abstract - A novel neuropilin-2 (NRP2) antibody for immunohistochemical staining of patient tissue samples
Y. Chong (San Diego, United States), S. Förster (Bonn, Germany), D. Siefker (San Diego, United States), Y. Becker (Bonn, Germany), E. Escobedo (San Diego, United States), L. Burman (San Diego, United States), K. Rauch (San Diego, United States), S. Paz (San Diego, United States), C. Burkart (San Diego, United States), A. Cubitt (San Diego, United States), M. Muders (Bonn, Germany), L. Nangle (San Diego, United States)
| |